• N/A
    Market Cap
  • -72.95%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 32
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

U.S. stock futures declined on Wednesday as investors await a Supreme Court ruling on Trump's tariff authority. The Consumer Price Index rose 2.7% year-over-year in December, matching expectations, while core CPI came in slightly below forecasts at 2.6%. Major indices including the Dow Jones, S&P 500, and Nasdaq 100 all declined in premarket trading. Notable movers include Wells Fargo reporting earnings, BP announcing a $5 billion writedown in energy transition businesses, WeRide launching a robotaxi service on WeChat, and TG Therapeutics providing optimistic 2026 guidance.

01/14/2026, 8:36 AM • Benzinga

Peers

Statistics

More
Day Range
$0.48
$0.48
$0.48
1-Year Range
$0.39
$2.95
$0.48
Latest Close$0.48
Change
-$0.0007 (-0.14%)
Volume12,163
Shares Outstanding9.4M
P/E (TTM)-0.68
Diluted EPS (TTM)-$0.72

Information as of 06/02/2026

Company Profile

N/A
Market Cap
-$6.6M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Monash Innovation Labs, Clayton, VIC, Australia, 3800
61 3 9087 3990

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Key Executives

  • Simon Hayden Szewach
  • Bradley Glenn Karp
  • Thuy-Linh Gigler
  • Nathan Jacob Givoni
  • Paul Wynne

Current Ownership Distribution

  • Other7.7M (83.71%)
  • Insiders1.5M (16.29%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)